InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (8 ops.)
Discover the full record of transactions filed by TANG KEVIN C, Director. Insider active across 3 companies, notably La Jolla Pharmaceutical Co. In total, 12 reports have been published. Total volume traded: €8.8m. The latest transaction was filed on 29 November 2021 — Cession. Regulator: SEC (Form 4). All data is free.
Declarations12 total
€702,288193,403 shares@ €3.631268.7% of flow
Common Stock
SEC:0001209191-21-067347·
€702,288193,403 shares@ €3.631234.4% of flow
Common Stock
SEC:0001209191-21-067347:0·
€2m161,336 shares@ €12.027684.4% of flow
Common Stock
SEC:0001209191-21-066910·
€2m161,336 shares@ €12.027634.43% mcap42.2% of flow
Common Stock
SEC:0001209191-21-066910:0·
€358,20743,213 shares@ €8.289315.6% of flow
Common Stock
SEC:0001209191-21-066146·
€358,20743,213 shares@ €8.28936.35% mcap7.8% of flow
Common Stock
SEC:0001209191-21-066146:0·
€1m468,849 shares@ €2.3481100.0% of flow
Common Stock
SEC:0001209191-21-065826·
€1m468,849 shares@ €2.348150.0% of flow
Common Stock
SEC:0001209191-21-065826:0·
€4,7441,286 shares@ €3.68930.5% of flow
Common Stock
SEC:0001209191-21-036939·
Ideal exit: 21 Feb 2022 (T+270)
€4,7441,286 shares@ €3.68930.2% of flow
Common Stock
SEC:0001209191-21-036939:0·
Ideal exit: 21 Feb 2022 (T+270)
€314,569104,403 shares@ €3.01330.8% of flow
Common Stock
SEC:0001209191-21-035962·
Ideal exit: 18 Feb 2022 (T+270)
€314,569104,403 shares@ €3.01315.4% of flow
Common Stock
SEC:0001209191-21-035962:0·
Ideal exit: 18 Feb 2022 (T+270)
12 of 12 declarations
About TANG KEVIN C
Kevin C. Tang is a Board Member and Chief Executive Officer of La Jolla Pharmaceutical Co., Odonate Therapeutics, Inc., and Aptevo Therapeutics Inc. In his roles, he oversees the strategic and operational leadership of the three companies. Kevin Tang plays a key role in developing new therapeutic solutions and optimizing the performance of the companies. His expertise in biopharmacy and management is essential for the success of these companies.
